Tamsulosin
| 250px | |
| 250px | |
| Systematic (IUPAC) name | |
|---|---|
|
(R)-5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzene-1-sulfonamide
|
|
| Clinical data | |
| Trade names | Flomax |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a698012 |
| Licence data | US FDA:link |
| Pregnancy category |
|
| Legal status | |
| Routes of administration |
oral |
| Pharmacokinetic data | |
| Bioavailability | 100% (oral) |
| Metabolism | hepatic |
| Biological half-life | 9–13 hours |
| Excretion | 76% renal |
| Identifiers | |
| CAS Number | 106133-20-4  |
| ATC code | G04CA02 (WHO) |
| PubChem | CID: 129211 |
| IUPHAR/BPS | 488 |
| DrugBank | DB00706 |
| ChemSpider | 114457 |
| UNII | G3P28OML5I |
| KEGG | D08560 |
| ChEBI | CHEBI:9398 |
| ChEMBL | CHEMBL836 |
| Chemical data | |
| Formula | C20H28N2O5S |
| Molecular mass | 408.51 |
|
|
|
|
| (verify) | |
Tamsulosin (rINN) (/tæmˈsuːloʊsᵻn/ or /tæmsᵿˈloʊsᵻn/) is an α1aadrenergic receptor antagonist used in the symptomatic treatment of benign prostatic hyperplasia (BPH). Tamsulosin was developed by Yamanouchi Pharmaceuticals (now part of Astellas Pharma) and was first marketed in 1996 under the trade name Flomax, and also under the name Omnic.
Tamsulosin is used in the treatment of difficult urination, a common symptom of enlarged prostate. Tamsulosin, and other medications in the class called alpha blockers, work by relaxing bladder neck muscles and muscle fibers in the prostate itself and make it easier to urinate.[1]
The U.S. patent for Flomax expired in October 2009.[2] The U.S. Food and Drug Administration (FDA) approved generic Flomax in March 2010.[3]
Contents
Mechanism
<templatestyles src="Module:Hatnote/styles.css"></templatestyles>
Tamsulosin is a selective α1 receptor antagonist that has preferential selectivity for the α1A receptor in the prostate versus the α1B receptor in the blood vessels.[4]
When alpha 1 receptors in the bladder neck and the prostate are blocked, this causes a relaxation in smooth muscle and therefore less resistance to urinary flow. Due to this, the pain associated with BPH can be reduced.
Selective action of tamsulosin in alpha 1A/D receptors is controversial and over three quarters of tamsulosin registered human studies are unpublished.[5]
Clinical uses
Tamsulosin is primarily used for benign prostatic hyperplasia, but can also assist the passage of kidney stones by the same mechanism of smooth muscle relaxation via alpha antagonism.[6][7] Tamsulosin is also used as adjunct treatment of acute urinary retention. Multiple studies have shown patients will void more successfully after catheter removal if they are taking tamsulosin vs. placebo. Patients taking tamsulosin are also less likely to need re-catheterization.[8][9][10] An additional use for tamsulosin is its use in medical expulsive therapy for some cases of nephrolithiasis.
Adverse effects
- Immunologic: Higher risk of allergic reaction in those with sulfa allergies.[11]
- Ophthalmologic: Patients taking tamsulosin are prone to a complication known as floppy iris syndrome during cataract surgery. Adverse outcomes of the surgery are greatly reduced by the surgeon's prior knowledge of the patient's history with this drug, and thus having the option of alternative techniques.[12]
- Severe hypotension.[13][14]
Tamsulosin has also affected sexual function in men. It can cause males to experience retrograde ejaculation.[15] In males, retrograde ejaculation occurs when the fluid to be ejaculated, which would normally exit the body via the urethra, is redirected to the urinary bladder. Normally, the bladder sphincter contracts and the ejaculate goes to the urethra, the area of least pressure. In retrograde ejaculation, this sphincter does not function properly. This side effect can be mitigated by exercising the sphincter muscle; this is done by practicing a pumping action during ejaculation and urination - some semen fluid can then be ejaculated.
Clinical comparison
Although prostate specific, it does not have the prostate apoptotic effects of other prostate drugs such as the 5 alpha-reductase inhibitors such as dutasteride and finasteride.[citation needed]
Use in combination therapy
The results of the CombAT (Combination of Avodart and Tamsulosin under the brand name Duodart) trial in 2008 demonstrated that treatment with the combination of dutasteride (Avodart) and tamsulosin provides greater symptom benefits compared to monotherapy with either agent alone for treatment of benign prostatic hyperplasia.[16] The CombAT trial became the medication Jalyn. It was approved by the FDA on June 14, 2010.[17] This combination can be useful as it can take up to six months for any symptomatic relief to be found by 5-alpha-reductase inhibitors such as dutasteride compared to alpha-1 receptor blockers which can provide relief in some cases within 48 hours.[18]
Brand names
Tamsulosin was first marketed in 1996 under the trade name Flomax. It is now marketed by various companies under licence, including Boehringer-Ingelheim and CSL. Tamsulosin hydrochloride extended-release capsules are marketed under the trade names Urisurge (India), Flomax, Flomaxtra, Contiflo XL, bestflo, Urimax and Pradif,[19] although generic, non-modified-release capsules are still approved and marketed in many countries (such as Canada). In Mexico, it is marketed as Secotex and as Harnal D in Japan and Indonesia and as Harnal Orca in Thailand.[20] In Egypt,[21] Italy and Iceland, it is marketed under the trade name Omnic by Astellas Pharma Europe. The largest manufacturer of tamsulosin is Synthon Biopharmaceuticals (The Netherlands).
References
- ↑ http://www.mayoclinic.com/health/prostate-gland-enlargement/DS00027/DSECTION=treatments-and-drugs
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ http://www.renalandurologynews.com/tamsulosin-aids-stone-expulsion/article/193855/
- ↑ http://www.prnewswire.com/news-releases/study-shows-use-of-tamsulosin-or-nifedipine-helps-patients-to-clear-ureteral-stone-fragments-faster-and-reduces-rate-of-recurrence-54518887.html
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ PharmacistAnswers Tamsulosin & Catheterization Retrieved February 12, 2014.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Medscape, Good Cataract Surgery Outcomes Possible in Intraoperative Floppy Iris Syndrome Due to Tamsulosin.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022460Orig1s000Approv.pdf
- ↑ Australian Medicines Handbook
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
- Tamsulosin – information from USP DI Advice for the Patient
- Flomax (drugs.com) – U.S. product information
- Product label U.S. Food and Drug Administration (FDA)
- Flomax (Official Site) - Official Site
